On 27.09.2021 EFSA published its conclusion on the peer review of benthiavalicarb.
28th September 2021
EFSA conclusion benthiavalicarb
28September
2nd March 2021
EFSA consultation metiram
02March
On 01.03.2021 EFSA opened a public consultation on the RAR for metiram, as well as on a draft Art. 4.7 report and its underlying documents.
2nd February 2021
EFSA consultation asulam
02February
On 02.02.2021 EFSA initiated a consultation on the peer review of asulam..
9th November 2020
EFSA consultation clofentezine: ED & Art.4.7
09November
On 06.11.2020 EFSA opened a public consultation on the updated RAR for clofentezine.
28th July 2020
benthiavalicarb ED & Art. 4.7 consultation
28July
EFSA opened on 27.07.2020 a public consultation on benthiavalicarb, regarding the assessments following the stop-the-clock for Endocrine Disruption assessment.
12th January 2020
Peer review of benthiavalicarb, metiram and dimethomorph delayed
12January
EFSA notified a delay in the renewal process of benthiavalicarb, metiram, and dimethomorph, due to Art. 4.7 reviews
15th March 2019
EFSA conclusions peer review & Art. 4.7 of thiacloprid published
15March
on 14.03.2019 EFSA published its conclusions on the peer review of thiacloprid.
14th August 2018
EFSA Art.4.7 report bromoxynil
14August
On 13.08.2018 EFSA published a scientific report on the necessity of bromoxynil as a herbicide to control a serious danger to plant health.